NASDAQ:BTTX

Better Therapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy BTTX

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 03, 2026

Better Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 23.43M and sold 0 BTTX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	23.43M shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 05, 2023 Buy	Common Stock A-Award	Berman Mark A. Chief Medical Officer	Officer	101 450 Value: $0
Mar 01, 2023 Buy	Stock Option (Right to Buy) A-Award	Berman Mark A. Chief Medical Officer	Officer	101 450 Value: $115.7K
Mar 01, 2023 Buy	Stock Option (Right to Buy) A-Award	Wynholds Kristin Chief Product Officer	Officer	101 450 Value: $115.7K
Mar 01, 2023 Buy	Stock Option (Right to Buy) A-Award	Heinen Mark Chief Financial Officer	C-Suite Officer	28 550 Value: $32.5K
Mar 01, 2023 Buy	Stock Option (Right to Buy) A-Award	Heinen Mark Chief Financial Officer	C-Suite Officer	28 550 Value: $32.5K
Mar 01, 2023 Buy	Stock Option (Right to Buy) A-Award	Wynholds Kristin Chief Product Officer	Officer	101 450 Value: $115.7K
Mar 01, 2023 Buy	Stock Option (Right to Buy) A-Award	Berman Mark A. Chief Medical Officer	Officer	101 450 Value: $115.7K
Nov 30, 2022 Buy	Common Stock A-Award	Heinen Mark See Remarks	Officer	15 723 Value: $19.5K
Nov 30, 2022 Buy	Common Stock A-Award	Wynholds Kristin Chief Product Officer	Officer	3 781 Value: $5K
Nov 30, 2022 Buy	Common Stock A-Award	Heinen Mark See Remarks	Officer	15 723 Value: $19.5K
Nov 30, 2022 Buy	Common Stock A-Award	Wynholds Kristin Chief Product Officer	Officer	3 781 Value: $5K
Sep 16, 2022 Buy	Common Stock P-Purchase	Perry David P See Remarks	Officer	39 156 Value: $81.0K
Sep 16, 2022 Buy	Common Stock P-Purchase	Perry David P See Remarks	Officer	39 156 Value: $81.0K
Sep 15, 2022 Buy	Common Stock P-Purchase	Perry David P See Remarks	Officer	10 844 Value: $21.6K
Sep 15, 2022 Buy	Common Stock P-Purchase	Perry David P See Remarks	Officer	10 844 Value: $21.6K
Sep 15, 2022 Buy	Common Stock P-Purchase	Karbe Frank See Remarks	Officer	50 000 Value: $104.7K
Sep 15, 2022 Buy	Common Stock P-Purchase	Karbe Frank See Remarks	Officer	50 000 Value: $104.7K
Sep 13, 2022 Buy	Common Stock P-Purchase	Heinen Mark See Remarks	Officer	26 132 Value: $50.7K
Sep 13, 2022 Buy	Common Stock P-Purchase	Heinen Mark See Remarks	Officer	26 132 Value: $50.7K
Sep 12, 2022 Buy	Common Stock P-Purchase	Heinen Mark See Remarks	Officer	23 868 Value: $46.3K
Sep 12, 2022 Buy	Common Stock P-Purchase	Heinen Mark See Remarks	Officer	23 868 Value: $46.3K
Jul 05, 2022 Buy	Stock Option (Right to Buy) A-Award	Karbe Frank See Remarks	Officer	472 200 Value: $793.3K
Jul 05, 2022 Buy	Common Stock J-Other	Karbe Frank See Remarks	Officer	0 Value: $0
May 31, 2022 Buy	Common Stock A-Award	Wynholds Kristin Chief Product Officer	Officer	5 023 Value: $8K
May 31, 2022 Buy	Common Stock A-Award	Wynholds Kristin Chief Product Officer	Officer	5 023 Value: $8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BETTER THERAPEUTICS, INC.

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also in...

Read Full Profile Here